Cite
MLA Citation
K C Koskinas et al.. “Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: insights from the PACMAN-AMI randomized trial.” European heart journal, vol. 43, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100168330208.0x000019